InsiderTrades

Form 4 for UTHR UNITED THERAPEUTICS Corp

Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-06 · accession 0001562180-25-002202 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2025-03-07 2025-03-06 UTHR MAHON PAUL A EVP, GC M - OptEx $163.30 +6,550 43.3K +18% +$1.07M
DT 2025-03-07 2025-03-06 UTHR MAHON PAUL A EVP, GC D - Sale to Iss $307.68 -6,550 36.8K -15% -$2.02M
DT 2025-03-07 2025-03-06 UTHR MAHON PAUL A EVP, GC M - OptEx $0.00 -6,550 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-06 M A 6,550 $163.30 43,331 D — — (F2) Includes 71 shares of common stock acquired on March 4, 2025 under the United Therapeutics Employee Stock Purchase Plan.
2 Common Common Stock 2025-03-06 D D 6,550 $307.68 36,781 D — — (F2) Includes 71 shares of common stock acquired on March 4, 2025 under the United Therapeutics Employee Stock Purchase Plan.
3 Derivative Share Tracking Award 2025-03-06 M D 6,550 $0.00 0 D $163.30 · 2016-03-13 to 2025-03-13 6,550 Common Stock (F3) Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.